COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium
Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Vaccine-induced immune thrombotic thrombocytopenia
In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …
and introduced at a remarkable speed. Although the vaccine introduction had a major …
Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia
MS Van Kammen, DA De Sousa, S Poli… - JAMA …, 2021 - jamanetwork.com
Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …
[图书][B] Stratégie mondiale en vue d'accélérer l'élimination du cancer du col de l'utérus en tant que problème de santé publique
World Health Organization - 2021 - books.google.com
Organisation mondiale de la Santé 2022 Certains droits réservés. La présente œuvre est
disponible sous la licence Creative Commons Attribution Pas d'utilisation commerciale …
disponible sous la licence Creative Commons Attribution Pas d'utilisation commerciale …
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
A Greinacher, K Selleng, J Mayerle… - Blood, The Journal …, 2021 - ashpublications.org
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe adverse effect of
ChAdOx1 nCoV-19 COVID-19 vaccine (Vaxzevria) and Janssen Ad26. COV2. S COVID-19 …
ChAdOx1 nCoV-19 COVID-19 vaccine (Vaxzevria) and Janssen Ad26. COV2. S COVID-19 …
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know
GM Arepally, TL Ortel - Blood, The Journal of the American …, 2021 - ashpublications.org
The development of vaccines to fight COVID-19 has been a remarkable medical
achievement. However, this global immunization effort has been complicated by a rare …
achievement. However, this global immunization effort has been complicated by a rare …
Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia
A Bourguignon, DM Arnold, TE Warkentin… - … England Journal of …, 2021 - Mass Medical Soc
The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is
recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia …
recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia …
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
RJ Perry, A Tamborska, B Singh, B Craven, R Marigold… - The Lancet, 2021 - thelancet.com
Background A new syndrome of vaccine-induced immune thrombotic thrombocytopenia
(VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous …
(VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous …